Drugs / APRIL CAR-T cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04657861 | May 2022 → Aug 2024 overdue | plasma cell myeloma, refractory plasma cell neoplasm | Zhejiang University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | APRIL CAR-T cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04657861 ↗ |
| Modality | Cell therapy | “APRIL CAR-T cells” NCT04657861 ↗ |